Volume 2, Issue 4 (Multidisciplinary Cancer Investigation 2018)                   Multidiscip Cancer Investig 2018, 2(4): 1-5 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Taheri A, khoshnevisan A, Alipour A, Khorasani G, Molaei H. Survival and recurrence in non- melanoma cancers of scalp. Multidiscip Cancer Investig. 2018; 2 (4) :1-5
URL: http://mcijournal.com/article-1-193-en.html
Abstract:   (47 Views)
Introduction: Non- melanoma scalp skin cancers including SCCs and BCCs are common. Their invasive characteristics especially in squamous cell carcinoma (SCC) need considerations to manage. Surveillance and mortality risks among SCCs and BCCs of scalp area, help us to choose proper approaches.
Methods and materials: 723 scalp non- melanoma cancers evaluated in a retrospective descriptive study according to their epidemiologic and clinical manifestations. Invasive extended tumor (IET) belonged to defined aggressive SCCs and BCCs which affect survival in patients. Therapies categorized in patients and all gathered data analyzed.
Results:723 patients including 228 SCCs and 495 BCCs evaluated in two compatible groups. Lymphatic metastasis, invasive extended tumor and higher stages in SCCs were significant. (p<.005) Mean and confidence interval 95% rates for SCCs and BCCs survival were 6.97 years ( 6.7- 7.25) and 7.6 years ( 7.46-7.73) respectively with significant difference between groups (p=0.001) and risk of mortality enhanced 2.05, 22.07 times in SCC and clinical manifestation as Invasive Extended Tumor respectively. Mean and confidential interval (95%) for Recurrence time among SCCs and BCCs were 1.74 (1.26-1.75) and 2.26 (1.63-2.37) respectively, which seems significant difference between groups (p=0.001).
Conclusion: Our retrospective showed BCC `s frequency was twice SCC `s without significant dominancy on gender or age in scalp area with significant number of Invasive, Extended Tumor (IET) cases in SCCs. Mortality risks enhanced 2.05 times in SCCs and risk of recurrence increased 1.85 times in BCCs. These knowledge can guide to proper approach. 
Full-Text [DOCX 34 kb]   (8 Downloads)    
Type of Study: Original/Research Article | Subject: Other
Received: 2018/03/29 | Accepted: 2018/09/22 | ePublished: 2018/11/26

Add your comments about this article : Your username or Email:

Send email to the article author

© 2018 All Rights Reserved | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb